A5073693596- Lymphoma Diagnosis and Treatment
- Viral-associated cancers and disorders
- Cutaneous lymphoproliferative disorders research
- CAR-T cell therapy research
- Platelet Disorders and Treatments
- Multiple Myeloma Research and Treatments
- Hematological disorders and diagnostics
- Digital Imaging for Blood Diseases
- Parasitic infections in humans and animals
- Renal and related cancers
- Breast Cancer Treatment Studies
- Parasitic Infections and Diagnostics
- Endometrial and Cervical Cancer Treatments
- Multiple and Secondary Primary Cancers
- Infectious Diseases and Tuberculosis
- Salivary Gland Tumors Diagnosis and Treatment
- Renal cell carcinoma treatment
- Reconstructive Surgery and Microvascular Techniques
- vaccines and immunoinformatics approaches
- Renal Diseases and Glomerulopathies
- MicroRNA in disease regulation
- AI in cancer detection
- Sarcoidosis and Beryllium Toxicity Research
- Chronic Lymphocytic Leukemia Research
- IgG4-Related and Inflammatory Diseases
Thammasat University
2006-2024
Thammasat University Hospital
2014
Mahidol University
2005
Abstract Systemic reports on the descriptive epidemiology of non‐Hodgkin lymphoma (NHL) from Southeast Asia are scarce. A nationwide multi‐institutional registry was conducted to compare histopathology, clinical features, and survival Thai adult patients with NHL using large registries, especially those Far East (FEA). Using a web‐based system, 13 major medical centers 4 geographic regions Thailand prospectively collected, 2007 2014, diagnostic pathology, according World Health Organization...
Abstract Background MYC/BCL2 double expression (DE) is associated with poor prognosis in patients diffuse large B-cell lymphoma (DLBCL) receiving rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP). This study aimed to determine whether the addition of DE National Comprehensive Cancer Network Internal Prognostic Index (NCCN-IPI) could improve prediction disease progression DLBCL treated R-CHOP. Methods confirmatory prognostic factor retrospectively recruited...
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) has received increasing interest among plastic surgeons as a long-term complication of breast augmentation. Although the prognosis is usually good, mortality possible outcome. Most cases reported in past two decades have been from United States, Europe, and Australia, whereas BIA-ALCL Asia remain rare. Herein, we describe first known case Thailand, which 32-year-old woman developed 3 years after augmentation using textured...
Objective: The previously reported kappa/lambda ratio cut-offs for plasma cell clonality by immunohistochemistry were in different values. This study aimed to identify the with highest accuracy diagnosis of multiple myeloma.Methods: Bone marrow specimens consecutively recruited between January 2011 and March 2019. patients at least 18 years old clinical suspicion myeloma had bone ≥10% CD138 immunohistochemistry. index test was immunohistochemical stains ratio. reference standard classify as...
ABSTRACT The initiation of veno-venous extracorporeal membrane oxygenation (VV-ECMO) has been opposed in late-phase acute respiratory distress syndrome (ARDS) due to an increase mortality. Herewith individual case a 20-year-old female who survived severe ARDS after breast augmentation is reported, whose delayed transfer our tertiary referral center led late VV-ECMO and multiple mechanical ventilation-associated complications. Nonetheless, her was decannulated 45 days onset, considering awake...
Background Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma. The standard first-line therapy for DLBCL consists of rituximab cyclophosphamide doxorubicin vincristine and prednisone (R-CHOP). About 50–70% patients may be cured by R-CHOP. There was no data on external validation comparison international prognostic index, revised-IPI (R-IPI), enhanced-IPI (NCCN-IPI) to predict treatment outcomes in middle-income country with a resourced-limited setting.Objectives We...
A 38-year-old pregnant woman (gravid 2, para 1) presented to the delivery room with labour pain at 38 weeks’ gestation. Her past medical history was unremarkable, normal menstrual cycle and no...
Mesenchymal stromal cells (MSCs) have recently been shown to play an important role in the growth and progression of many solid tumors, including cholangiocarcinoma (CCA). The human placental amniotic membrane (hPAM) is one most favorable sources MSCs due its availability non-invasive harvesting procedure. However, mesenchymal (hPAMSCs) CCA has not yet determined. This study investigates effects conditioned medium derived from hPAMSCs (PA-CM) on properties three cell lines explores possible...